Atopic Dermatitis Clinical Trials

A study of the saftey, effectiveness and tolerability of an investigational treatment for individuals with atopic dermatitis. REF: x40-CLN

A 52-week, multicenter, randomized, double-blind study of secukinumab (300mg) to demonstrate efficacy as assessed by psoriasis area and severity index and investigator's global assessment after 12 weeks of treatment, compared to ustekinumab, and to assess long-term safety, tolerability, and efficacy in subjects with moderate to severe plaque psoriasis.

Do you have a bad case of eczema? Eczema is a term for several medical conditions that cause the skin to be irritated, inflamed and often to itch. Atopic dermatitis is the most common form of eczema and therefore the type that many pharmaceutical companies are trying to develop new ...

This research study will evaluate the effectiveness and safety of two concentrations (0.5 percent [%] and 1%) and two application frequencies (once a day and twice a day) of GSK2894512 cream for the topical treatment in adolescent and adult subjects with atopic dermatitis (eczema). Results from this study will be ...

The study doctor and Regeneron are conducting this research study of an investigational drug called dupilumab. The main purpose of this study is to collect long term safety data on adult subjects with moderate-to-severe atopic dermatitis who have previously been administered dupilumab.

A Phase 3 Study Investigating the Efficacy And Safety of Multiple Dupilumab Dose Gimens Administered as Monotherapy for Maintaining Treatment Response in Patients with Atopic Dermatitis

If so, you are not alone. Millions of people of all ages struggle with eczema and symptoms such as patches of itchy, dry, thickened, cracked, or scaly skin, usually on the hands, feet, arms, and legs. Some people with eczema, struggle with chronic itching (extended periods of constant itching) despite ...

A study to evaluate safety and effectiveness of Asimadoline in adult subjects with eczema (atopic dermatitis).

A study to evaluate the safety and effectiveness of a new, unmarketed, version of Tacrolimus Ointment 0.1% compared to Protopic 0.1% or a placebo ointment in subjects with eczema (atopic dermatitis).

Study to evaluate the safety and effectiveness of a generic Pimecrolimus Cream 1%, to Elidel Cream 1% and to placebo cream, when used in subjects with eczema (atopic dermatitis).